Global Medical Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Connect with this vendor - Learn about this product

Nublexa 40mg (Regorafenib)

Manufacturer: Bayer Pharmaceuticals Pvt Ltd

Brand Name: Nublexa Tablets
Content: Regorafenib 40mg
Strength: 40 mg
Form: Tablets
Packing: Pack of 28 Tablets

Nublexa 40mg Tablet is a drug targeted basically on cancerous diseases. The main method of its function is blocking cancer cells proteins which encourages growth of such cells, hence its also known as cancer growth blocker. FDA in 2017 has expanded the indications of Nublexa 40mg Tablet to include hepatocellular carcinoma. It has been also included as a potential cure agent for multiple types of tumor. It is administered to treat and delay tumor growth in patients with gastrointestinal stromal tumors. It is indicated for treating colorectal cancer as well.

Ask for Quote: info@mbapharmaceuticals.com

Specialty: